15-67750719-C-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_145160.3(MAP2K5):c.1134+2118C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.28 in 152,022 control chromosomes in the GnomAD database, including 6,748 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.28 ( 6748 hom., cov: 31)
Consequence
MAP2K5
NM_145160.3 intron
NM_145160.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.280
Publications
27 publications found
Genes affected
MAP2K5 (HGNC:6845): (mitogen-activated protein kinase kinase 5) The protein encoded by this gene is a dual specificity protein kinase that belongs to the MAP kinase kinase family. This kinase specifically interacts with and activates MAPK7/ERK5. This kinase itself can be phosphorylated and activated by MAP3K3/MEKK3, as well as by atypical protein kinase C isoforms (aPKCs). The signal cascade mediated by this kinase is involved in growth factor stimulated cell proliferation and muscle cell differentiation. Three alternatively spliced transcript variants of this gene encoding distinct isoforms have been described. [provided by RefSeq, May 2011]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.509 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| MAP2K5 | NM_145160.3 | c.1134+2118C>G | intron_variant | Intron 19 of 21 | ENST00000178640.10 | NP_660143.1 | ||
| MAP2K5 | NM_002757.4 | c.1104+2118C>G | intron_variant | Intron 18 of 20 | NP_002748.1 | |||
| MAP2K5 | NM_001206804.2 | c.1026+2118C>G | intron_variant | Intron 19 of 21 | NP_001193733.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.279 AC: 42442AN: 151904Hom.: 6727 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
42442
AN:
151904
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.280 AC: 42504AN: 152022Hom.: 6748 Cov.: 31 AF XY: 0.281 AC XY: 20846AN XY: 74292 show subpopulations
GnomAD4 genome
AF:
AC:
42504
AN:
152022
Hom.:
Cov.:
31
AF XY:
AC XY:
20846
AN XY:
74292
show subpopulations
African (AFR)
AF:
AC:
13205
AN:
41438
American (AMR)
AF:
AC:
6474
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
AC:
1255
AN:
3472
East Asian (EAS)
AF:
AC:
2707
AN:
5156
South Asian (SAS)
AF:
AC:
1705
AN:
4818
European-Finnish (FIN)
AF:
AC:
1561
AN:
10558
Middle Eastern (MID)
AF:
AC:
86
AN:
294
European-Non Finnish (NFE)
AF:
AC:
14785
AN:
67986
Other (OTH)
AF:
AC:
615
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1528
3056
4583
6111
7639
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
428
856
1284
1712
2140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.